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5 March 2010 Farewell address: Tussenbalans
My address given on the occasion of my retirement as 
professor of Medical Pharmacology describes how I became 
interested in research on stress in the brain, how a typical 
career in science proceeds and the highlights celebrated during 
my career. The objective of this adventure in science was 
to understand how the stress hormone cortisol can tip the 
balance from health to disease. What is the cause and what 
are the consequences? The new knowledge leads to medicines 
targeting the mechanism of stress adaptation itself to boost 
resilience and recovery from mental disorders. To achieve this 
goal an enormous database has been obtained over the past 
years, but the real breakthrough awaits a smart experiment. 
Thus, time for refl ection, a ‘Tussenbalans’. 
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Mijnheer de Rector Magnifi cus, Decaan van het Leids 
Universitair Medisch Centrum, zeer gewaardeerde toehoorders,
 
My inaugural address was on November 1, 1991.1 A few weeks 
ago, after some searching, I found the text again and I was 
astounded. Everything we have explored over the past 20 years 
was already included in that address! However, the 1991 text 
was much more impressive; perhaps because at that time we 
were not yet inhibited by the facts. 
The title of my inaugural address was: ‘Equilibrium in a 
changing world’.1 Meanwhile the world has indeed changed a 
lot over the past 20 years. We are digitalized and mobile. It’s 
all about hypes and scoring points, euro’s and the greenhouse 
effect. Everybody is incredibly busy. We are stressed, but is 
that a problem? Stress or coping with challenges is an essential 
requirement in life which is all to do with adaptation and 
recovery. Stress gives us the strength to do just a little bit extra; a 
crisis, that may help to get things back on the rails. Stress is the 
‘spice of life’2, as Selye the discoverer said. It is the key to health 
and vital ageing. That is what the 1991 address was about. It was 
also the theme of today’s symposium, a fantastic event.
This gives me a chance to thank my colleagues for this 
wonderful symposium. I have enjoyed every second, but I 
must make an apology. It is a tradition that an address given 
from the lectern is in Dutch. It is also without slides, so you 
are somewhat handicapped both in vision and sound. We 
have made a translation, though, so you can keep track of the 
proceedings. 
I would also like to express my gratitude that you have made 
the effort to come here. I would like to thank the guides in my 
life, the fellow combatants, the followers, and those who have 
put faith in me, and those who would have liked to do so but 
could not, or those who could but wouldn’t. In short, all of you 
that did join me and still join me in working on an exciting 
story in science. Of course my deepest gratitude is for Marian: 
a fountain of inspiration, a beacon, a ‘prachtmens’; and of 
course to Sybren our son, who has endured 20 years of living 
with two researchers, an important reason probably for the 
choice of his academic study, here in Leiden, a university to be 
proud of!
My address today consists of two parts. First something about 
the world of stress, how one lands in a job like this, the state of 
the art and where the science is going. Then, a few words about 
the life of the professor and his fi eld of science.
Stress in the brain
A very good friend of mine, the recently deceased Seymour 
(Gig) Levine, a pioneer in stress research, called the defi nition 
of stress a futile exercise. ‘Stress is’ he said ‘a composite, 
multidimensional construct, in which three components 
interact: the input (the stressor), the processing of the stressful 
information including the subjective experience and the output, 
the stress response, that is the spectrum of physiological and 
behavioural adaptations to restore homeostasis - the equilibrium 
of life processes-, which interact via complex self-regulating 
feedback loops.3 
The strongest stressor is: no control, no information to predict 
ongoing events, but with the uncertain anxious feeling that 
something bad is going to happen”. In fact, it is all about 
coping, the ability to deal with the stressor. If coping fails 
stress becomes pathogenic.2,4 Coping is not only dependent 
on previous experiences and genetic inputs, on cognitive and 
environmental inputs, but also on the context around the 
stressful situation. Such a context is determined according to 
Lazarus4 by psychosocial factors such as control, social position, 
a safe place and attachment. If any of these factors is disrupted - 
loss of dominance, homelessness, expulsion, lack of attachment 
- the challenge may exceed the coping resources resulting in 
strong emotional reactions ultimately leading to a condition of 
chronic stress and enhanced vulnerability to disease.
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To understand the reaction to a stressor better, we have studied 
the action of hormones secreted after the stressful challenge. 
I will not discuss adrenaline, you know - the hormone that 
makes the hairs on the back of your neck rise when you’re 
frightened. No, it’s all about cortisol secreted from adrenal 
glands into the bloodstream triggered by the brain. The 
hormone circulates in the blood and coordinates the function 
of all tissues and cells in response to the stressor. The hormone 
also easily penetrates the brain acting precisely in those brain 
regions that initially triggered the response to the stressor. 
One area is the amygdala from which fearful emotions and 
behaviour are triggered in the face of a threat. 
Another area targeted by cortisol is the hippocampus, a 
seahorse-shaped structure that receives particular attention 
from me. The hippocampus contains a special neural circuit 
that marks emotional experiences in place and context and 
stores the memories away in temporal fashion. The stronger 
the emotion, the stronger the memory. The hippocampus is of 
great importance for the communication between emotional 
information from the amygdala and cognitive processes 
underlying appraisal, dealing with the challenge and storage in 
the memory occurring elsewhere in the cortex.5
Cortisol targets precisely these brain areas that process 
the emotional and cognitive challenges in life. On the one 
hand, cortisol promotes emotional arousal, motivational 
and cognitive processes, but on the other hand it prevents 
the initial reactions to the stressor from overshooting and 
becoming damaging themselves. Cortisol acts on the battlefi eld 
of emotion and reason, which coincidentally is also the motto 
of the 435th anniversary of Leiden University, this year. 
How did I get caught up in this fi eld?
November 28th 1968 was an important day in my life. After 
completing my masters degree in chemistry I lost a gamble. 
The consequence was that not I, but my fellow student 
Willibrord applied for a much sought after PhD position at 
the Rudolf Magnus Institute in Utrecht. We had tossed a coin 
to decide who was going to apply, since we were confi dent the 
winner would get the job and indeed that is what happened. 
Willibrord got the job and I subsequently requested an 
appointment with Professor David de Wied. I explained that 
in spite of losing the gamble, I would really like to work under 
his supervision. “One moment”, the professor said, and he 
got on the phone and talked for a while with the Director of 
Organon at that time, dr Stefan Szpilfogel. When he fi nished 
talking David said: ‘You can start next Monday, 2nd December at 
Organon as a PhD student’. “Thank you very much professor”, 
I said politely, unaware of the impending 40 years that would 
bring me to this address in Leiden.
At Organon Johan van der Vies was my guide. His way of 
working was characterized by vigour, energy and taking the 
shortest route from A to B. This proved to be a wise lesson. 
As a PhD student I had to propose a research plan based on a 
recent discovery described in Nature6 by Bruce McEwen. This 
stated that cortisol surprisingly acted in the hippocampus 
and amygdala, which you may remember are precisely the 
areas which are of crucial importance for coping with fear, 
stress and memory performance. Our attitude was ‘we can 
do that better in the Netherlands’ and we took the much more 
potent synthetic analog of cortisol, dexamethasone. Whatever 
I tried, this potent compound did not enter the brain. It was 
only 30 years later that we discovered why: dexamethasone 
rather than corticosterone is readily pumped out of the brain, 
dexamethasone can’t get in.7 
Thus I sent a letter to Bruce McEwen in 1970, explaining my 
desperation in the face of my upcoming failure in science. 
Bruce wrote back: “By the way, are you by any chance a brother 
of Siwo de Kloet, a biochemist now in Tallahassee, Florida?” 
Indeed I was, and still am the brother of Siwo, who by the way 
now owns a biotech company in avian science, avianbiotech.
com. It transpired that Bruce had been working as a student 
with my brother. This exchange of letters eventually led to 
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a post-doc position. We had two marvellous years at the 
Rockefeller University in New York, which formed the basis 
for a longstanding collaboration with Bruce. This coming 
weekend, for instance, we are going to discuss with Nicole 
Datson the susceptibility pathways in the hippocampus that 
were identifi ed using an advanced DNA sequencing approach.8 
Susceptibility pathways are networks of genes that can tip the 
balance from health to mental disease. I am proud to be one of 
the sons in the McEwen family; in fact there are already great-
grandchildren.
After I returned to the Netherlands, I was appointed at the 
Rudolf Magnus Institute to work on something else: the 
neuropeptides, under the inspiring leadership of David de 
Wied. The ‘grand fi nale’ was in 1990: the canary experiment 
with David, Door and Carel ten Cate. We discovered that with 
the neuropeptide vasotocin song learning of canaries was 
promoted - they learned their song faster. For this purpose 
vasotocin acts in a brain area where still new neurons are being 
made to enable song learning. This beautiful stereotyped song 
displayed by the canaries is needed for demarcation of their 
territory to provide shelter to the canary bride.9
This action exerted by vasotocin illustrates how the 
neuropeptides just as hormones can coordinate in temporal 
fashion the whole spectrum of socio-sexual behaviours 
required for adaptation and reproduction from the fi rst social 
recognition through sexual intercourse to pregnancy and 
mothering the offspring.10 It was this type of research where 
David was at his best. David’s humour, and his ability to 
motivate and stimulate were important to me and while saying 
this I am also reminded of good friends like Wybren de Jong 
and Bela Bohus, who passed away far too soon.
In 1990 I was appointed professor in Medical Pharmacology and 
this gives me an opportunity to thank Douwe Breimer for the 
time he was my boss, rector and friend. My appointment was 
settled on 25th January, 1990, the day that the Netherlands was 
hit by a hurricane. I think most of you may still remember what 
you were doing at that particular time, using your hippocampus. 
20 years in Leiden
In Leiden I decided to focus on the mechanism underlying 
coping with stress which was actually initiated during my PhD 
period, but that was kept simmering at the Rudolf Magnus 
Institute while doing the neuropeptide stuff. I liked the stress 
topic, but also felt I should have a backup program in Utrecht 
in case the neuropeptide research didn’t work out. 
We focused on the question: How is it possible that cortisol, 
a hormone with such a crucial role in adaptation and health 
could change from being a protective to a damaging agent? 
What is the cause? What are the consequences? For this 
purpose I will just give 5 highlights that illustrate the progress 
in the fi eld. 
1: Cortisol is not only released after stress, but also 
rhythmically every hour. Those hourly pulses are crucial for 
maintaining the resilience of cells, tissues, and behaviour 
in case of an emergency when the hormone suddenly rises 
after stress. Your cortisol pulse is large in the morning in 
anticipation of a highly energetic day. Stafford Lightman11, 
present here, and his group with whom we collaborate, 
discovered that this pulsatile rhythm disappears and becomes 
chaotic in some, but not all, aging individuals marking 
the reduced ability to deal with challenges as one of the 
consequences. For medical science a simple lesson: please 
monitor the ultradian rhythm of cortisol, and reinstate 
during glucocorticoid therapy the pulsatility for the sake of 
homeostasis, resilience and mental health. Also, if because of 
mental disorder cortisol levels are chronically elevated, then 
not only the normal cortisol level, but also the rhythm can be 
reinstated with glucocorticoid antagonists. 
2: Cortisol activates in the amygdala, hippocampus and part 
of the cortex two closely related receptor proteins in the cell: 
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the mineralocorticoid and glucocorticoid receptors; for the 
‘connaisseur’ MR en de GR.12 This work, initially inspired while 
working with Bruce, started at the Rudolf Magnus Institute 
in the 80’s with the help of Win Sutanto, Dick Veldhuis, Anke 
van Eekelen, Anna Ratka, Hans Reul and many others. The 
fi nding was as George Fink pointed out a ‘gold mine’.13 From 
that moment it was possible to systematically study, measure 
and interpret stress effects in the brain. The properties and the 
precise localization of the receptors provided the criteria for 
performing experiments from gene to behaviour and beyond. 
Before I continue this gives me the chance to highlight that 
communication in the brain is neuroanatomically determined 
and electrical. Miklos Palkovits14 taught me that in order to 
understand the brain, one needs to know the precise position 
of nerve cells like a chess player, how they are organized in a 
network and operate in time, space and context. A hell of a 
job, but if you like geography and chess, it can be hobby. It was 
a great help in bridging the gap between cells, brain function 
and behaviour.
In our behavioural studies, Melly Oitzl discovered that the 
MR enhances the stress reactivity, which is being terminated 
by the GR. At the same time coping with the experience is 
being stored in the memory in preparation for the future. 
The balance in the two receptor-mediated activities appeared 
crucial for emotional reactivity and optimal cognitive 
performance, and hence for coping with challenges. Now some 
years later the behavioural analysis is much more advanced. 
For instance the MR controlling stress reactivity, actually has 
an important infl uence on processes of appraisal and choice of 
the behavioural response to deal with a stressor.15 
The clinical application is obvious: post traumatic stress 
syndrome - where intrusive memories are part of the disorder 
- are expected to be manageable using drugs that directly target 
the stress response system. Hence trials with beta blockers and 
cortisol antagonists are beginning to be successful provided 
the drugs are applied in the context of memory performance. 
Likewise, blockade of an overactive stress system during 
depression and psychoses is also effective. 
3: Cortisol action is complex. Be aware that the receptor is 
encoded by 1 gene, but occurs in dozens of genetic variants, so-
called single nucleotide polymorphisms or SNPs. In addition 
the receptor is surrounded in the cell by at least a few dozen 
proteins that in different patterns can enhance or suppress 
the activity of the receptor in the control of gene expression. 
Then, there are about 6000 genes that appear responsive 
under different conditions, experiences and behaviours in 
response to the environment via cortisol. However, in spite 
of this enormous potential for diversity in cortisol action, 
the hormone feeds back on that particular neural circuit 
that underlies processing of specifi c stressful information 
via complementary MR- and GR-mediated responses. This 
action exerted by cortisol is coordinated with its actions on 
e.g. energy metabolism, plasticity and other processes, also 
elsewhere in brain and body in order to promote adaptation to 
the environment.
Onno Meijer investigates a mechanism that is responsible for 
specifi city in this myriad of cortisol actions, and he found 
evidence that signalling cascades selective for neuroendocrine 
regulation can be discriminated from emotional and cognitive 
processes.16 A cortisol-like compound devoid of damaging side 
effects is badly needed, it might very well be possible. 
4: The gene variants of the cortisol receptor machinery 
possibly can be used as biomarkers in predicting how an 
individual will deal with a stressor, and to what extent 
vulnerability or resilience is affected. It is a hot area in which 
the Max Planck Institute for Psychiatry under the leadership of 
Florian Holsboer, honorary doctor of the University of Leiden, 
is very successful. They have identifi ed a number of single 
nucleotide polymorphism’s (SNP’s) that are very promising 
for the prediction of successful therapy or vulnerability to 
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mental disease.17 It is a privilege to have witnessed how the 
MPIP developed into one of world’s leading research institutes 
dedicated to mental health. Locally, on a more modest scale 
Roel de Rijk and his group in collaboration with Frans 
Zitman’s Psychiatry Department have identifi ed a combination 
of SNPs, a haplotype in the MR that is associated with 
dispositional optimism, a really interesting fi nding.18 
5: Corticosterone and cortisol can program emotional 
reactivity in developing rodent and primate brains. Normally, 
in the fi rst days of life the olfactory neurons of a young 
pup are stimulated to ensure recognition of the mother, 
but if the pups are separated from the mother for longer 
periods corticosterone rises and activates in the amygdala 
fear-motivated and withdrawal behaviour.19 If prolonged, 
the anxiety center becomes programmed for the rest of life 
by likely modifying via epigenetic processes the expression 
of the receptors for cortisol. You can’t say whether this is 
good or bad. Recently, a prize winning contribution by 
Danielle Champagne20 demonstrated that indeed early 
life programming for enhanced stress reactivity enhances 
performance in later life under stressful circumstances. In 
other words it seems metaphorically that a programmed highly 
reactive stress system is an outstanding asset for the stressful 
life of a bank manager, mountain climber or skating coach, 
but disastrous for the dull life of a bureaucrat. The lesson: 
experiences in early life should preferably match with later life 
circumstances. 
However, ‘nothing is written in stone’ was once one of the 
famous sayings of Gig Levine, and Jonathan Seckl has 
demonstrated that the senescent brain is plastic in structure 
and function, for instance by treatment with anti-depressants.21 
In rodents in a special place of the hippocampus, stem cells 
can generate new neurons, and the group of Erno Vreugdenhil 
and Carlos Fitzsimons discovered that the integration of these 
newborn cells into the hippocampal circuitry depends on 
corticosterone.22
In our research we have the great pleasure of a close and 
fruitful collaboration with the group of Marian Joëls and 
Henk Karst, currently at the Utrecht Medical Center. Thanks 
to Marian and Henk we now know much better how 
glucocorticoids like cortisol and corticosterone act in the 
brain on cellular excitability. Their most recent discovery 
revealed that the very same receptors that slowly regulate 
the transcription of genes, can also promote excitation very 
quickly.23 It is a discovery with an enormous impact, because 
it points to a mechanism explaining how cortisol can promote 
stress reactions rapidly, which are then slowly suppressed to 
prevent them from overshooting.  
To summarize, I hope to have clarifi ed for you:
Firstly, that coping with stress via study of the action 
mechanism of cortisol can be measured and interpreted 
in terms of specifi c signalling pathways in the brain. Using 
systems biology approaches in an approach that one could 
call ‘the endgame’ (re: the genome structure is known) in 
unravelling genes and proteins organized in pathways, a lot can 
be learned giving the illusion that pathways can be mapped. In 
my humble opinion a real breakthrough in this timely business 
is only possible if this unprecedented new systems knowledge 
is combined with a smart experiment. Such an experiment 
could take into account that environmental input determines 
the brain’s activity, which in turn provides the context to 
cells governing the molecular changes we are so fond of. 
Glucocorticoids power this environmental input from brain to 
molecule.
Secondly, cortisol signalling is a determining factor in 
resilience, needed for counteracting chronifi cation of mental 
and neurodegenerative disorders. Genetic variants seem 
promising as biomarkers and novel steroid modulators with 
fewer side effects may very well substantiate personalized 
medicine in the treatment of stress-related diseases. This is 
needed more than ever, since depression and anxiety disorders 
8
Prof. Dr. E.R. de Kloet
are estimated to cost 150 billion euro’s annually with about 60 
million patients, second only to cardiovascular disease.24 
Thirdly, stress-related brain disorders are characterized by 
the inability to adapt properly to the outside world. This 
implies that dysregulation of stress hormone regulation 
actually impairs adequate processing of environmental 
information. If stress hormones are dysregulated vulnerability 
to metabolic, cardiovascular and neurodegenerative diseases 
is also enhanced. The threat to mental health is most extreme 
when by damage to the hippocampus adaptation to stress is 
not possible at all as is perhaps the case in Alzheimer Disease. 
Medicines capable of preventing or postponing the onset or 
progression of Alzheimer are urgently needed. Meanwhile, 
since the patient is incapable of adapting to change, one 
could say this individual depends on the reverse: adaptation 
of the environment to the individual during this phase of the 
lifespan.25 
The Life of a Professor
In an ideal world research is driven by curiosity. The University 
creates the conditions for outstanding performance in research 
and teaching, in the case of the LUMC top research into 
disease and medicine. A discovery gives a euphoric feeling, 
the manuscript is easily written and your work is immediately 
published by a friendly editor in one of the top journals. 
Funding fl ows into your laboratory. The university rector and 
faculty deans carry you through downtown Leiden on their 
shoulders while singing: ‘for he’s a jolly good fellow’.
 
The reality is not quite the same. A retired colleague of mine, 
Pieter Smelik26, noted that the male scientist shows some 
similarity with a vulcano: if he is slumped in his chair with 
smoke spiralling upwards (he occasionally takes a cigar from 
his own box) people say: ‘look, he’s working’. But cigar smoking 
at work is a thing of the past. The scientist these days is a busy 
little chap: he has meetings all day long, markets science, sells 
brain work as being relevant for clinics and society, valorises 
fi ndings, organizes fi nancing for start-ups and manages 
fi nance for research. The scientist must publish, but only in 
journals that have a high impact factor. 
These new trends have prompted mixed responses from 
those who do the work and as an example I quote a fragment 
from a recent editorial of Alan Fersht in the Proceedings of 
National Academy of Sciences (PNAS)27: ‘The terrible legacy of 
impact factor is that it is being used to evaluate scientists rather 
than journals, which has become of increasing concern to many 
of us. But some burocrats want a simple metric. Judgment of 
individuals is, of course, best done by in-depth analyses by expert 
scholars in the subject area’. My experience of being on review 
committees is that more notice is taken of impact factors when the 
committee members do not have the knowledge to evaluate the 
science independently’. 
That does not deter from the pleasure of publishing 
occasionally in Nature or Science, and we are proud when 
this happens. However, the most innovative fi ndings and 
breathtaking discoveries are usually in sound author-friendly 
specialist journals. I suspect by the way that ten years from 
now the whole hocus-pocus around impact factors will be 
outdated and that ‘data mining’ can readily uncover the results 
of publicly fi nanced research on the internet. Why not, if 
your mobile phone is already outdated half a year from now? 
Reputations can then be based once again on real fi ndings and 
scientifi c oeuvre. 
We have had the fortune to work at the Leiden/Amsterdam 
Center for Drug Research, a smooth operation thanks to 
effective management and visionary leadership. More recently, 
we benefi t from the thriving Leiden Institute of Brain and 
Cognition, and the launching of the Leiden Center for 
Translational Neuroscience that together with an established 
Leiden Center for Genome Technology meet each other in 
at least three University-wide research profi le areas. With 
the Centre of Human Drug Research and the LACDR it is 
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obvious that the Leiden niche in the national and international 
neuroscience arena will have a pharma accent integrating 
technological platforms from cognitive science to imaging and 
gene technology. 
By focusing on research profi le areas, education will also 
benefi t. The student can have the opportunity to feel the 
vibrations of frontline multidisciplinary research, which 
can then get further emphasis if interaction with mentors is 
promoted by confrontation. This implies a model in which 
the student is confronted with tasks and has to demonstrate 
initiative and cooperation, an approach that appeared 
successful in the international schools we fi rst organized 
with William Rostene28 some 25 years ago, always in secluded 
Mediterranean locations.
I am proud therefore that the staff of Medical Pharmacology 
was occasionally awarded the ‘best teacher’ award and that in 
collaboration with Endocrinology and other Departments the 
course on Hormones and Brain earned the qualifi cation ‘best 
course’ of the year. I wish my colleagues much success in the 
new minor and master structure of cognitive neurosciences, 
the biomedical and biopharmaceutical sciences. However, 
there is one important condition to be fulfi lled: the advice of 
Franciscus Agricola who, thanks to my colleague Henk Jan de 
Jonge, could not have said it better: 
‘Vacásne parúmper míhi? Resérva áliquid témporis mihi‘ 
or in good Dutch: ‘heb je even voor mij? maak wat tijd voor mij 
vrij?’ 
In the past decades we have been supported by the 
Netherlands Foundation for Scientifi c Research, the Royal 
Netherlands Academy of Arts and Sciences, EU programs, 
Heart Foundation, Brain Foundation, and the International 
Foundation for Alzheimer Research, Organon, Corcept 
Therapeutics, and more recently through TI Pharma Lundbeck 
in Denmark. We are grateful for their support. All of this, 
of course, could only be possible through the faith in our 
endeavours by Leiden University Medical Center, also in 
critical times, and the hospitality and support by the staff of 
the Gorlaeus Laboratory. 
Over the past 20 years hundreds of students, PhD students 
and post-docs have been guided through our department and 
steered towards a fantastic career thanks to the tenured staff 
of about 10 individuals. In this address I have occasionally 
mentioned someone in particular, but believe me everyone is 
equally close to my heart, since all the time there has been a 
friendly, enthusiastic and creative atmosphere. A special word 
of thanks however I would like to give to Ellen Heidema for 
her style of personal and management assistance from 1990-
2008. Her effi cient and warm performance has been quietly 
continued by Wendy Rodger, a great relief in this complicated 
time.
To close, the science at the interface of pharmacology, 
endocrinology and the neurosciences is traditionally strong 
in the Netherlands as is apparent from the legacy of Ernst 
Laqueur, Marius Tausk and the Leiden scientists Sam de Jongh 
and Peter van Rees amalgamated with the ideas of David de 
Wied. I am proud therefore to wear the toga of my predecessor 
Sam de Jongh from 1935. In the light of these heroes of the 
past I realize that the future will be characterized by enormous 
technical innovations. Naturally, the classical disciplines 
physiology, endocrinology and pharmacology will always 
retain their relevance. I quote Marius Tausk at the foundation 
of the Netherlands Endocrine Society on May 10th, 1947, who 
stated: 
‘Endocrinology is a concept, an approach, or even can be 
considered a method. Whatever the specifi c endocrine sub-
discipline, topic or subject might be, the binding element is the 
objective, which is the understanding how signals coordinate the 
processes in cells, tissues and organs’.29  
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In line with this I have substantiated my commitment via 
teaching and research in the area of neuropsychopharmacology 
of hormones, this implies how hormones and drugs can 
affect the brain, in which we defi ne the mind for the sake 
of convenience as the product of the brain’s activity. The 
neuropharmacology explains how psychotropic drugs act 
and what their impact is on neuropathology and psychiatric 
disorders. 
Neuropsychopharmacology has a long tradition: already 
thousands of years ago the Phoenicians used extracts of a 
Sardinian variant of the Oenanthe Crocata, to get a grin on 
the face of superfl uous 65+ individuals. During the ceremony 
the drugged pensionado was thrown from a rock into the 
sea. Louis van Gasteren, the famous moviemaker drew my 
attention to very recent research showing that the so-called 
‘Sardonian smile’ displayed by the victim during sacrifi ce was 
caused by a hallucinogen and a Gaba-ergic blocker inducing 
convulsions and rigidity of the facial nerve.30 
The smiling 65-plusser obviously did not return. Ron de 
Kloet will also not return, but in this case because he is not 
actually leaving. This gives me the opportunity to thank the 
Royal Netherlands Academy of Sciences for awarding me the 
Academy professorship in 2004. The appointment based on 
this award has been prolonged for a number of years, I suspect 
because there are no rocks yet in Leiden to fi nish the job. 
However, in science the job is never fi nished, hence time for a 
moment of relfection, a ‘Tussenbalans’.
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My address given on the occasion of my retirement as 
professor of Medical Pharmacology describes how I became 
interested in research on stress in the brain, how a typical 
career in science proceeds and the highlights celebrated during 
my career. The objective of this adventure in science was 
to understand how the stress hormone cortisol can tip the 
balance from health to disease. What is the cause and what 
are the consequences? The new knowledge leads to medicines 
targeting the mechanism of stress adaptation itself to boost 
resilience and recovery from mental disorders. To achieve this 
goal an enormous database has been obtained over the past 
years, but the real breakthrough awaits a smart experiment. 
Thus, time for refl ection, a ‘Tussenbalans’. 
